Safety and efficacy of the DragonFly system for transcatheter valve repair of degenerative mitral regurgitation: one-year results of the DRAGONFLY-DMR trial

CONCLUSIONS: The DRAGONFLY-DMR trial contributes to increasing evidence supporting the safety and efficacy of TEER therapy, specifically the DragonFly system, for treating patients with chronic symptomatic DMR 3+ to 4+ at prohibitive surgical risk.PMID:38389469 | DOI:10.4244/EIJ-D-23-00361

Source: EuroIntervention - February 23, 2024 Category: Cardiovascular & Thoracic Surgery Authors: Jian'an Wang Xianbao Liu Zhaoxia Pu Mao Chen Zhenfei Fang Jun Jin Jianzhen Dong Yansong Guo Biao Cheng Jiancheng Xiu Jianfang Luo Yida Tang Yan Wang Xiaomen Chen Gejun Zhang Yibing Shao Guangyuan Song Lang Hong Hong Jiang Yangqin Wu Yiqiang Yuan Lianglong Source Type: research